Jessica Polka | |
---|---|
Nationality | American |
Other names | J. K. Polka |
Alma mater | University of California, San Francisco (PhD) University of North Carolina at Chapel Hill ( (BS) |
Scientific career | |
Institutions | ASAPbio Whitehead Institute Harvard Medical School |
Thesis | Diversity in the bacterial cytoskeleton: Assembly, structure, and cellular mechanisms of AlfA, a plasmid segregating actin from B. subtilis (2015) |
Doctoral advisor | Dyche Mullins |
Other academic advisors | Pamela Silver |
Website | www |
Jessica Polka is a biochemist and the Executive Director of ASAPbio (Accelerating Science and Publication in biology), a non-profit initiative promoting innovation and transparency via preprints and open peer review. [1] She was one of the organizers of a recent meeting they held on scholarly communication. [2]
Polka received a BS in biology from the University of North Carolina at Chapel Hill in 2007. While there, she was a Morehead Scholar. [3] She obtained a Ph.D. in biochemistry from the University of California, San Francisco under the supervision of Dyche Mullins in 2012. [4]
In 2013 Polka became a research fellow in the department of Systems Biology at Harvard Medical School with Pamela Silver as advisor. [5] She was also held a visiting scholar at the Whitehead Institute in Massachusetts. Polka conducted research in the assembly, function, and applications of protein polymers in bacteria, such as membrane-breaking protein needles called R bodies. [6] Polka's work on R bodies was discussed in the American magazine The Atlantic, [7] and covered by the American Chemical Society. [8] Polka discovered that carboxysome, a protein organelle in cyanobacteria, grows like a crystal until it is coated by a layer of shell proteins. [5]
Polka was co-chair of the American Society for Cell Biology's COMPASS (Committee for Postdocs and Students) during 2013 and 2014. [4]
Polka is on the steering committee for Rescuing Biomedical Research, an initiative to discuss solutions to problems addressed in the April 2014 PNAS article "Rescuing US biomedical research from its systemic flaws". [4] [9]
Polka is recognised as having insight into issues surrounding open peer review, preprint and early career progression, and has been quoted in numerous articles by Nature and Science on these topics. [10] [11] [12] [13] [14] [15] [ non-primary source needed ] In 2015, Polka and Viviane Callier wrote an article for the careers column in Nature where they argue that funding agencies should support more than 16% of postdocs through fellowships. This would allow postdocs to "strike out away from the beaten path [and] will bring fresh ideas and approaches to the table". [16]
Polka was one of the organisers of the first Future of Research Symposium in Boston in 2014. She was on the executive committee until she became president of the board of directors in 2016. [17] Polka is involved in creating debate amongst early-career scientists about the financial, historical and political influences on academic research. Future of Research was awarded the People of the Year award in 2015 by Science journal for their "efforts to empower early-career and aspiring scientists...". [18]
Polka was a founder of ASAPbio which began in 2015 after Ron Vale showed that University of California, San Francisco students were taking a long time to publish and proposed that preprinting might mitigate the issue. [19] Vale recruited Polka, Daniel Colon-Ramos and Harold Varmus which led to the first ASAPbio meeting in February 2016 attended by scientists, representatives from funding agencies, journals and preprint servers. [20] The meeting Polka led was widely recognized as a turning point in scholarly communication [2] [21] [22] and a catalyst moment in the so-called "preprint revolution" in biology and science more generally. [23] Polka began working full-time at ASAPbio in 2016 after funding was granted from the Simons Foundation, Sloan Foundation, Arnold Foundation, and Gordon and Betty Moore Foundation. [24]
In 2016 Polka was described in the journal Nature as an "agent of change" for explaining how junior researchers can increase the impact of their work. For instance, ASAPbio encourages preprints within biology. [25] ASAPbio tries to mitigate the effect of lengthy waiting times before publications are reviewed and published, following the example of physics, computer science and maths, fields that have already adopted preprints. She has also taken an interest in strategies for preventing sexual harassment in the scientific community. [26] In 2017, PLOScast interviewed Polka about her work which contributes to the changing way that science is published. [27]
Since 2019, ASAPBio has begun to host open databases to collate information about academic publishing practices. [28] [29] ReimagineReview tracks the different peer review policies and models of academic journals, with a focus on experimental forms of peer review. [28] [30] [31] The Transpose database extends on this to cover journal policies including on peer review, co-reviewing, preprints, licensing, and versioning. [29] [32] [33]
In academic publishing, a preprint is a version of a scholarly or scientific paper that precedes formal peer review and publication in a peer-reviewed scholarly or scientific journal. The preprint may be available, often as a non-typeset version available free, before or after a paper is published in a journal.
Timothy John Mitchison is a cell biologist and systems biologist and Hasib Sabbagh Professor of Systems Biology at Harvard Medical School in the United States. He is known for his discovery, with Marc Kirschner, of dynamic instability in microtubules, for studies of the mechanism of cell division, and for contributions to chemical biology.
Marc Wallace Kirschner is an American cell biologist and biochemist and the founding chair of the Department of Systems Biology at Harvard Medical School. He is known for major discoveries in cell and developmental biology related to the dynamics and function of the cytoskeleton, the regulation of the cell cycle, and the process of signaling in embryos, as well as the evolution of the vertebrate body plan. He is a leader in applying mathematical approaches to biology. He is the John Franklin Enders University Professor at Harvard University. In 2021 he was elected to the American Philosophical Society.
The Instituto Gulbenkian de Ciência (IGC) is an international centre for biological and biomedical research and graduate training based in Oeiras, Portugal. Founded by the Calouste Gulbenkian Foundation (FCG) in 1961, and still supported by the Foundation, the IGC is organised in small independent research groups that work in an environment designed to encourage interactions with minimal hierarchical structure.
The American Society for Cell Biology (ASCB) is a professional society that was founded in 1960.
Open peer review is the various possible modifications of the traditional scholarly peer review process. The three most common modifications to which the term is applied are:
Axel Meyer is a German evolutionary biologist and a professor of zoology and evolutionary biology at the University of Konstanz, Germany.
eLife is a not-for-profit, peer-reviewed, open access, science publisher for the biomedical and life sciences. It was established at the end of 2012 by the Howard Hughes Medical Institute, Max Planck Society, and Wellcome Trust, following a workshop held in 2010 at the Janelia Farm Research Campus. Together, these organizations provided the initial funding to support the business and publishing operations. In 2016, the organizations committed US$26 million to continue publication of the journal.
Diethard Tautz is a German biologist and geneticist, who is primarily concerned with the molecular basis of the evolution of mammals. Since 2006 he is director at the Max Planck Institute for Evolutionary Biology in Plön.
The San Francisco Declaration on Research Assessment (DORA) is a statement that denounces the practice of correlating the journal impact factor to the merits of a specific scientist's contributions. Also according to this statement, this practice creates biases and inaccuracies when appraising scientific research. It also states that the impact factor is not to be used as a substitute "measure of the quality of individual research articles, or in hiring, promotion, or funding decisions".
bioRxiv is an open access preprint repository for the biological sciences co-founded by John Inglis and Richard Sever in November 2013. It is hosted by the Cold Spring Harbor Laboratory (CSHL).
Sarah M. Assmann is an American biologist known for her research on plants and signal transduction. She is an elected fellow of the American Association for the Advancement of Science.
Miranda Robertson is a scientific editor. She is known for serving as Biology Editor at Nature from 1983 to 1992, during which time Nature's visibility and influence in the life sciences substantially increased, and for her contributions to the influential textbook Molecular Biology of the Cell. As editor of BMC's open-access Journal of Biology, she introduced pioneering improvements in the process of peer review, including the ability for authors to opt out of re-review.
Rebecca W. Heald is an American professor of cell and developmental biology. She is currently a Professor in the Department of Molecular & Cell Biology at the University of California, Berkeley. In May 2019, she was elected to the National Academy of Sciences. She has published over 120 research articles in peer reviewed journals.
Kenneth D. Poss is an American biologist and currently James B. Duke Professor of Cell Biology and director of the Regeneration Next Initiative at the Duke University School of Medicine.
Zhiping Weng is the Li Weibo Professor of biomedical research and chair of the program in integrative biology and bioinformatics at the University of Massachusetts Medical School. She was awarded Fellowship of the International Society for Computational Biology (ISCB) in 2020 for outstanding contributions to computational biology and bioinformatics.
Susanne Marie Rafelski is an American biochemist. Rafelski studied biochemistry at the University of Arizona with David Galbraith. She obtained her PhD in 2005 from Stanford University, under supervision of Julie Theriot.
Jan Steyaert is a Belgian bioengineer and molecular biologist. He started his career as an enzymologist but the Steyaertlab is best known for pioneering work on (engineered) nanobodies for applications in structural biology, omics and drug design. He is full professor and teaches biochemistry at the Vrije Universiteit Brussel and Director of the VIB-VUB Center for Structural Biology, one of the Research Centers of the Vlaams Instituut voor Biotechnologie (VIB). He was involved in the foundation of three spin-off companies: Ablynx, Biotalys, and Confo Therapeutics.